4//SEC Filing
Clark Daniel Grant 4
Accession 0001104659-22-091237
CIK 0001792581other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:26 PM ET
Size
5.6 KB
Accession
0001104659-22-091237
Insider Transaction Report
Form 4
Clark Daniel Grant
Chief Financial Officer
Transactions
- Award
Common Stock
2022-08-11+50,000→ 62,770 total
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs were granted pursuant to an executive employment agreement entered into by and between the reporting person and the issuer dated February 14, 2022, pursuant to which the reporting person was entitled to receive a grant of 150,000 RSUs. For the purpose of managing the issuer's equity incentive plan pool, the reporting person and the issuer agreed that 50,000 RSUs would be granted on August 11, 2022, vesting immediately, and the remaining 100,000 RSUs would be granted as soon as the issuer deems appropriate and practical.
- [F2]Includes (i) 50,000 shares of common stock underlying the RSUs, (ii) 6,866 shares of common stock and (iii) 5,904 shares of restricted stock.
Documents
Issuer
Kiromic Biopharma, Inc.
CIK 0001792581
Entity typeother
Related Parties
1- filerCIK 0001888103
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:26 PM ET
- Size
- 5.6 KB